Robin Lee1, Suzanne Malfair2, Jordan Schneider3, Sukjinder Sidhu4, Caitlin Lang4, Nina Bredenkamp4, Shu Fei Sophie Liang5, Alice Hou4, Adil Virani6. 1. , BScPharm, BSc, is a Pharmacist with the Surrey Memorial Hospital and the Jim Pattison Outpatient Care and Surgery Centre, Surrey, British Columbia. 2. , BSc(Pharm), ACPR, PharmD, FCSHP, BCPS, is Coordinator, Clinical Pharmacy Services, with Lions Gate Hospital and The University of British Columbia, North Vancouver, British Columbia. 3. , PharmD, MS, BCPS, is a Clinical Pharmacist with the Jim Pattison Outpatient Care and Surgery Centre, Surrey Memorial Hospital, Surrey, British Columbia. 4. , BSc(Pharm), ACPR, is a Clinical Pharmacist with Surrey Memorial Hospital, Surrey, British Columbia. 5. , BSc(Pharm), is a Pharmacist with Surrey Memorial Hospital, Surrey, British Columbia. 6. , BSc(Pharm), PharmD, is the Manager of Pharmacy Services, Lower Mainland Pharmacy Services, and Associate Professor, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
Abstract
BACKGROUND: Discharge medication reconciliation (Discharge MedRec) was implemented on one unit at a large urban teaching hospital, and was to be expanded across the rest of the hospital and the health authority's various sites by the end of 2018. Clinical pharmacists on the Acute Care for the Elderly unit carried out discharge planning and led Discharge MedRec during a pilot period, to inform the future implementation. OBJECTIVES: The primary objective was to examine the number and type of medication discrepancies before and after implementation of Discharge MedRec. The secondary objectives were to compare documented medication changes, pharmacist recommendations, discharge counselling, communication with community pharmacists, polypharmacy, and 30-day readmission rates. METHODS: Patients seen in December 2015 constituted the control (pre-implementation) group, who received usual care. Patients seen from January to April 2016 constituted the intervention group, for whom pharmacists performed Discharge MedRec and other discharge activities as per the hospital-to-home checklist of the Institute for Safe Medication Practices Canada. RESULTS: There were 66 patients in the control group and 306 in the intervention group. Median discrepancies per patient decreased from 6.5 to 3 (p = 0.007), median number of documented changes without rationale increased from 2 to 3 (p = 0.01), and median number of documented changes with rationale increased from 1 to 2 (p < 0.001). Pharmacists made a per-patient median of 1 progress note recommendation in the control group and 2 progress note recommendations in the intervention group (p = 0.007), and a per-patient median of 2 orders in both the control and intervention groups (p = 0.62). Median recommendation acceptance was 100% for both groups, but twice as many recommendations were made per patient for the intervention group. Discharge counselling increased from 22.7% to 65%. Communication with community pharmacists increased from 10.6% to 60.8%. CONCLUSIONS: Clinical pharmacist involvement improved Discharge MedRec planning and documentation. Decreases in medication discrepancies, combined with an increase in discharge counselling, should improve continuity of care across the health care team and increase patient adherence with medication therapy. This study further demonstrates the leadership role that pharmacists play in the assessment and clear documentation of medication changes at all transitions of care.
BACKGROUND: Discharge medication reconciliation (Discharge MedRec) was implemented on one unit at a large urban teaching hospital, and was to be expanded across the rest of the hospital and the health authority's various sites by the end of 2018. Clinical pharmacists on the Acute Care for the Elderly unit carried out discharge planning and led Discharge MedRec during a pilot period, to inform the future implementation. OBJECTIVES: The primary objective was to examine the number and type of medication discrepancies before and after implementation of Discharge MedRec. The secondary objectives were to compare documented medication changes, pharmacist recommendations, discharge counselling, communication with community pharmacists, polypharmacy, and 30-day readmission rates. METHODS: Patients seen in December 2015 constituted the control (pre-implementation) group, who received usual care. Patients seen from January to April 2016 constituted the intervention group, for whom pharmacists performed Discharge MedRec and other discharge activities as per the hospital-to-home checklist of the Institute for Safe Medication Practices Canada. RESULTS: There were 66 patients in the control group and 306 in the intervention group. Median discrepancies per patient decreased from 6.5 to 3 (p = 0.007), median number of documented changes without rationale increased from 2 to 3 (p = 0.01), and median number of documented changes with rationale increased from 1 to 2 (p < 0.001). Pharmacists made a per-patient median of 1 progress note recommendation in the control group and 2 progress note recommendations in the intervention group (p = 0.007), and a per-patient median of 2 orders in both the control and intervention groups (p = 0.62). Median recommendation acceptance was 100% for both groups, but twice as many recommendations were made per patient for the intervention group. Discharge counselling increased from 22.7% to 65%. Communication with community pharmacists increased from 10.6% to 60.8%. CONCLUSIONS: Clinical pharmacist involvement improved Discharge MedRec planning and documentation. Decreases in medication discrepancies, combined with an increase in discharge counselling, should improve continuity of care across the health care team and increase patient adherence with medication therapy. This study further demonstrates the leadership role that pharmacists play in the assessment and clear documentation of medication changes at all transitions of care.
Authors: Vincent C Tam; Sandra R Knowles; Patricia L Cornish; Nowell Fine; Romina Marchesano; Edward E Etchells Journal: CMAJ Date: 2005-08-30 Impact factor: 8.262
Authors: Jacqueline D Wong; Jana M Bajcar; Gary G Wong; Shabbir M H Alibhai; Jin-Hyeun Huh; Annemarie Cesta; Gregory R Pond; Olavo A Fernandes Journal: Ann Pharmacother Date: 2008-10 Impact factor: 3.154
Authors: Bruce E Koehler; Kathleen M Richter; Liz Youngblood; Brian A Cohen; Irving D Prengler; Dunlei Cheng; Andrew L Masica Journal: J Hosp Med Date: 2009-04 Impact factor: 2.960
Authors: Ulrika Gillespie; Anna Alassaad; Dan Henrohn; Hans Garmo; Margareta Hammarlund-Udenaes; Henrik Toss; Asa Kettis-Lindblad; Håkan Melhus; Claes Mörlin Journal: Arch Intern Med Date: 2009-05-11